NexgenRx Inc. (TSXV:NXG)

NexgenRx Income Statement

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	17.93	16.48	13.85	12.78	11.84
Revenue Growth (YoY)	8.84%	18.99%	8.33%	7.94%	7.25%
Cost of Revenue	3	3.35	3.03	2.6	2.03
Gross Profit	14.93	13.12	10.82	10.18	9.81
Selling, General & Admin	11.63	10.8	9.79	8.62	6.41
Depreciation & Amortization Expenses	1.22	1.27	1.31	1.41	1.33
Other Operating Expenses	0.12	-	-	-	-
Total Operating Expenses	12.97	12.06	11.1	10.03	7.75
Operating Income	1.96	1.06	-0.28	0.16	2.07
Interest Expense	-0.03	-0.03	-0.03	-0.02	-0.06
Total Non-Operating Income (Expense)	-0.03	-0.03	-0.03	-0.02	-0.06
Pretax Income	1.94	1.03	-0.31	0.13	2.01
Provision for Income Taxes	0.65	0.41	0.03	0.16	-2.01
Net Income	1.29	0.61	-0.33	-0.02	4.02
Net Income to Common	1.29	0.61	-0.33	-0.02	4.02
Net Income Growth	109.86%	-	-	-	89.90%
Shares Outstanding (Basic)	71	71	71	70	70
Shares Outstanding (Diluted)	77	77	71	70	75
Shares Change (YoY)	0.68%	8.51%	0.28%	-6.01%	0.88%
EPS (Basic)	0.01	0.01	-0.01	-	0.06
EPS (Diluted)	0.01	0.01	-0.01	-	0.05
EPS Growth	180.00%	-	-	-	86.21%
Shares Outstanding	71.12	70.93	70.53	70.34	70.34
Free Cash Flow	4.68	1.06	1.2	0.68	3.7
Free Cash Flow Growth	339.62%	-11.31%	77.23%	-81.69%	46.03%
Free Cash Flow Per Share	0.06	0.01	0.02	0.01	0.05
Dividends Per Share	0.015	0.010	0.010	0.010	-
Dividend Growth	50.00%	-	-	-	-
Gross Margin	83.28%	79.65%	78.14%	79.67%	82.87%
Operating Margin	10.94%	6.42%	-1.99%	1.23%	17.44%
Profit Margin	7.19%	3.73%	-2.40%	-0.18%	33.93%
FCF Margin	26.10%	6.46%	8.67%	5.30%	31.23%
EBITDA	3.18	2.32	1.03	1.56	3.4
EBITDA Margin	17.76%	14.11%	7.45%	12.22%	28.72%
EBIT	1.96	1.06	-0.28	0.16	2.07
EBIT Margin	10.94%	6.42%	-1.99%	1.23%	17.44%
Effective Tax Rate	33.37%	40.14%	-8.82%	116.66%	-99.91%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.